Commentary on apomorphine versus sildenafil for erectile dysfunction

被引：2

作者：

Carson, Culley C. ^{[1
]}

机构：

[1] Univ N Carolina, Dept Urol, Chapel Hill, NC 27515 USA

来源：

JOURNAL OF UROLOGY | 2008年 / 179卷 / 05期

关键词：

D O I：

10.1016/j.juro.2008.03.002

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S95 / S96

页数：2

相关论文

共 5 条

[1] Central nervous system-acting agents and the treatment of erectile and sexual dysfunction [J].

Carson III C.C. .

Current Urology Reports, 2007, 8 (6) :472-476

[2] An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist [J].

Diamond, Lisa E. ;

Earle, Dennis C. ;

Heiman, Julia R. ;

Rosen, Raymond C. ;

Perelman, Michael A. ;

Harning, Ronald .

JOURNAL OF SEXUAL MEDICINE, 2006, 3 (04) :628-638

[3] An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction [J].

Eardley, I ;

Wright, P ;

Macdonagh, R ;

Hole, J ;

Edwards, A .

BJU INTERNATIONAL, 2004, 93 (09) :1271-1275

[4]

Porst H, 2007, EUR J MED RES, V12, P61

[5] Salvage of sildenafil failures with bremelanotide: A randomized, double-blind, placebo controlled study (Publication with Expression of Concern) [J].

Safarinejad, Mohammad Reza ;

Hosseini, Seyyed Yousof .

JOURNAL OF UROLOGY, 2008, 179 (03) :1066-1071